Related Experiment Video

Updated: Jul 19, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

[Is hyperuricemia a cardiovascular risk factor?]

Krzysztof Chizyński1, Monika Rózycka

  • 1Zakładu Kardiologii Inwazyjnej Uniwersytetu Medycznego w Lodzi.

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|October 5, 2006
PubMed

Insights

Elevated serum uric acid (hyperuricemia) is linked to coronary artery disease (CAD) risk factors like hypertension and obesity. Its role as an independent cardiovascular risk factor remains debated, potentially reinforcing existing risks.

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Disorders
  • Epidemiology

Context:

  • Elevated serum uric acid (hyperuricemia) is frequently observed alongside traditional coronary risk factors.
  • Numerous studies have investigated the link between hyperuricemia and coronary artery disease (CAD) or myocardial infarction (MI).
  • Hyperuricemia is associated with hypertension, high body mass index (BMI), and lipid disorders (dyslipidemia), including elevated triglycerides and low high-density lipoprotein cholesterol.

Purpose:

  • To analyze the association between elevated serum uric acid and coronary risk factors.
  • To explore the relationship between hyperuricemia and the presence and severity of coronary artery disease.
  • To determine if uric acid is an independent cardiovascular risk factor or a marker of other risk factors.

Summary:

  • Hyperuricemia is linked to hypertension, obesity, and dyslipidemia, which are established cardiovascular risk factors.
  • While some studies show a correlation between serum uric acid levels and CAD presence/severity, particularly in women, the direct causal link is debated.
  • Hyperuricemia may indirectly promote CAD progression through lifestyle factors like reduced physical activity leading to obesity.

Impact:

  • Clarifies the complex relationship between uric acid, metabolic syndrome, and cardiovascular disease.
  • Highlights hyperuricemia as a potential marker or contributor to cardiovascular risk.
  • Informs clinical practice regarding the assessment and management of patients with hyperuricemia and cardiovascular risk factors.

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...